Brief Admission for Adolescents Who Self-harm

NCT04962373 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 59

Last updated 2025-08-06

No results posted yet for this study

Summary

There is still no consensus on how to manage suicidal behavior in youth with recurrent self-harm at times when the risk for suicide is imminent (1). Brief Admission (BA) has evolved as a promising crisis intervention for adults with self-harm (2). The characteristics of BA is different from other types of admission, being focused on prevention through increased autonomy and self-care, based on structured and voluntary brief self-referrals to hospital (3). As a result of a randomized controlled trial, BA is since January 2019, continuously offered to adults with self-harm at risk for suicide in Skåne (4). Parallel to this clinical trial, the method has been adapted to work in a psychiatric setting for adolescents. At present 24 adolescents have access to the method in Skåne. Clinical experiences from staff are promising, however, the lived experiences have not been collected in a standardized way.

The aim of the present study is to gather information on how BA in its present, standardized form works for adolescents, their loved ones and staff working at the ward providing BA. This will be done through semi-structured interviews with:

1. Adolescents using BA and their loved ones
2. Staff working at the ward providing BA. Data will be analyzed with qualitative analysis (5, 6). The ultimate aim is to use these results to optimize the current standardized version of BA for adolescents in order to test in a randomized clinical trial.

Conditions

  • Self-Harm, Deliberate
  • Suicide, Attempted
  • Suicidal
  • Non-Suicidal Self Injury

Interventions

OTHER

Semi-structured interviews

Each participant will attend a 30-60 minute semi-structured interview conducted by the CI

Sponsors & Collaborators

  • Lund University

    collaborator OTHER
  • Region Skane

    lead OTHER

Eligibility

Min Age
13 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04962373 on ClinicalTrials.gov